Results 121 to 130 of about 448,470 (384)

Screening for Social Determinants of Health in Patients With Systemic Lupus Erythematosus: A Point‐of‐Care Feasibility Study

Arthritis Care &Research, EarlyView.
Objective Social determinants of health (SDoH) can impact outcomes but are not routinely screened for in US outpatient rheumatology clinics. This study determined the feasibility of routine point‐of‐care SDoH screening among patients with systemic lupus erythematosus (SLE) and associated barriers and facilitators at the physician, care team, and ...
S. Sam Lim, Vijay R. Nadipelli, Michelle Bruno, Daphne Lew, Bernard Rubin, Charmayne M. Dunlop‐Thomas, Kelsey Hulcher, Kristi R. Mitchell, Lydia Demetriou, Jeff Berko, Jason Bao, Alfred H. J. Kim   +11 more
wiley   +1 more source

Pain in systemic connective tissue diseases [PDF]

, 2015
Pain is frequent in patients with connective tissue diseases (CTDs), particularly those affected by systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) in which it is virtually ubiquitous and can have different causes.
Atzeni, Fabiola, Bazzichi, Laura, Casale, Roberto, DI FRANCO, Manuela, Sarzi Puttini, Piercarlo   +4 more
core   +1 more source

THE COMORBID CONDITIONS IN RHEUMATOLOGICAL PRACTICE: PARANEOPLASTIC SYNDROME PROBLEM

Вісник проблем біології і медицини, 2019
The malignant tumor, irrespective of its localization and stage of its development, is capable to provoke complex aggressive autoimmune and metabolic responses.
Zhdan V. M., Volchenko H. V., Babanina M. Y., Tkachenko M. V., Khaimenova H. S.   +4 more
doaj   +1 more source

Agreement of administrative pharmacy dispensing with self‐reported use of oral prednisone in US Veterans with rheumatoid arthritis

Arthritis Care &Research, Accepted Article.
Objective Administrative claims are used to evaluate oral glucocorticoid use in rheumatoid arthritis (RA), despite limited evidence to support accuracy. We aimed to evaluate the performance of claims‐based algorithms for glucocorticoid use compared to self‐report in an RA population.
Beth I. Wallace, Bryant R. England, Joshua F. Baker, Michael D. George, Brian C. Sauer, Jorge Rojas, Punyasha Roul, Katherine D. Wysham, Hannah Brubeck, Isaac Smith, Liron Caplan, Paul A. Monach, Gail S. Kerr, Gary Kunkel, Tawnie Braaten, Ted R. Mikuls, Grant W. Cannon   +16 more
wiley   +1 more source

Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis. [PDF]

, 2018
To compare disease burden and biologic use among psoriatic arthritis (PsA) or rheumatoid arthritis (RA) patients recruited to the Corrona registry. Retrospective study of patients with PsA or RA enrolled in Corrona between January 2002 and March 2013 and
Etzel, Carol J, Greenberg, Jeffrey D, Griffith, Jenny, Karki, Chitra, Kavanaugh, Arthur, Kremer, Joel M, Singh, Rakesh   +6 more
core   +1 more source

Time trends and predictors of gout remission over six years

Arthritis Care &Research, Accepted Article.
Objectives This study aims to describe the trends in remission rates over six years of follow‐up among people with gout taking urate‐lowering therapy (ULT), and to identify variables that predict remission. Methods A post hoc analysis was conducted using data from the Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (CARES ...
Adwoa Dansoa Tabi‐Amponsah, Sarah Stewart, Greg Gamble, Lisa K Stamp, William J Taylor, Nicola Dalbeth   +5 more
wiley   +1 more source

Supplementum 271: Abstracts of the Annual meeting of the Swiss Society of Rheumatology

Swiss Medical Weekly, 2023
Swiss Society of Rheumatology
doaj   +1 more source

Physiotherapy for patients with rheumatic inflammatory diseases - towards a theoretical platform for clinical practice

Fysioterapeuten, 2021
Objective: To clarify theoretical understanding underpinning physiotherapy practice for patients with rheumatic inflammatory diseases. Methods: Physiotherapists at Lillehammer Rheumatism Hospital in Norway, and a researcher collaborated to clarify ...
Anne Marit Mengshoel, Anne Svarstad, Gunhild Blegen, Arvid Elveseter, Ragnhild Ildstad, Tiril Vehus, Heidi Starheim Løvaas, Ingvild Bø   +7 more
doaj  

Where, how, and how much? A multicenter cohort study of the relationship between lupus decision aid modality, place of administration, interruption and viewing completeness and patient‐reported outcomes

Arthritis Care &Research, Accepted Article.
Objective We assessed whether shared decision‐making (SDM), and patient acceptability, feasibility, and overall satisfaction with a computerized patient decision aid (PtDA) for patients with systemic lupus erythematosus (SLE), differs by PtDA setting, modality, and the viewing experience.
Jasvinder A. Singh, Mark Beasley, Larry R. Hearld, for the Implementing DEcision‐Aid for Lupus in clinics (IDEAL) Consortium   +3 more
wiley   +1 more source

Treating lupus nephritis patients to lupus low disease activity reduces renal relapse and preserves long‐term kidney function

Arthritis Care &Research, Accepted Article.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE) but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment, and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond YH Yap, KL Lee, Philip H Li, Iris YK Tang, Chak Sing Lau, Shirley CW Chan   +6 more
wiley   +1 more source